Naringenin can inhibit cancer progression through various mechanisms, like inducing apoptosis, cell cycle arrest, inhibiting angiogenesis, and modifying various signaling pathways, including Wnt/β- Catenin, PI3K/Akt, NF- κB and TGF- β Pathway (78). The gene discussed is AKT1; the disease is cancer.